Hearing loss: Vector overcomes barrier to gene therapy delivery

Nature Reviews Drug Discovery 16, 238 (2017). doi:10.1038/nrd.2017.58 Author: Katie Kingwell No drug has yet been approved to treat hearing loss, and alternative strategies such as cochlear implants only partly restore hearing function. Now, two papers from researchers at Harvard Medical School report the ability of a synthetic adeno-associated virus (AAV) vector to efficiently deliver a

http://feeds.nature.com/~r/nrd/rss/current/~3/CV44owdRn3I/nrd.2017.58

Source: Nature Reviews Drug Discovery - March 30, 2017 Category: Drugs & Pharmacology Authors: Katie Kingwell Tags: Research Highlight Source Type: research